XFOR
X4 Pharmaceuticals, Inc
NASDAQ · Healthcare · Biotechnology · US
$3.24
+2.21%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 29.94x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.07x
- Price / sales
- 20.27x
- Price / cash flow
- -3.84x
Enterprise value
- Enterprise value
- $190.5M
- EV / sales
- 12.02x
- EV / EBITDA
- -2.39x
- EV / EBIT
- -2.17x
- Market cap
- $321.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026